TuCADD Tuebingen Center for Academic Drug Discovery
Therapeutic Approaches: Small Molecules,
Therapeutic Areas of Expertise: Immunology, Oncology, Regenerative Medicine
Center/Program Highlights:
Our centre combines strong expertises in RNAi based target discovery, modelling/virtual screening and medicinal chemistry. New therapeutic targets (main programs: cancer and regenerative medicine) are functionally identified via in vitro or in vivo shRNA screening. Prioritized targets are subjected to thorough functional validation in predictive preclinical mouse models. Genetically validated targets are then subjected to an established virtual screening plattform. Hits can be validated by re-synthesis and wet lab assays. The centre has access to fully established medicinal chemistry units with a track record of 3 first into man projects.
Further information can be found at
http://www.medchem.uni-tuebingen.de/
Sources of Funding: Federal/State, University
Institutional Affiliation(s): Eberhard Karls University and University Hospital Tuebingen
Address:
Auf der Morgenstelle 8
Tuebingen
Baden-Wuerttemberg, 72076
Germany
Center/Program Start Date: 2012
Number of Employees: 50+
